Bluenote, a San Francisco, CA-based generative AI platform for all times sciences corporations, raised $10M in financing.
The spherical was led by Lux Capital, with participation from Elad Gil, Anthropic & Menlo Ventures Anthology Fund, McKesson Ventures, Avichal Garg/Electrical Capital, Moxxie Ventures, Carbon Silicon Ventures, and leaders in AI and life sciences – Othman Laraki (CEO Colour Well being), Fidji Simo (CEO Instacart, Co-founder Metrodora Institute, OpenAI Board), Mike Nohaile (CEO Prellis Biologics, beforehand Amgen & Novartis Govt), Kristen Fortney (CEO BioAge), Eric Morgen (COO BioAge), Qasar Younis (CEO Utilized Instinct), Linus Upson (Verily), and Jeffrey Low (Life sciences investor).
The corporate intends to make use of the funds to broaden its platform to help further workflows.
Co-founded by Fatima Sabar and Katsuya Noguchi, Bluenote has developed a generative AI expertise platform for all times sciences corporations to streamline regulatory workflows and convey their improvements to sufferers asap. At the moment, the platform’s most generally used functions concentrate on producing regulatory filings, technical reviews, protocols, Normal Working Procedures (SOPs), validation reviews, danger analyses, manufacturing documentation and extra. The corporate has deployed 15+ functions for scientists, engineers, high quality, regulatory and manufacturing groups.
FinSMEs
23/12/2024
